DrugBiological
Omfiloctocog alfa clinical trials
Also written SCT800.
Keep track of what changes. Save the omfiloctocog alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2019 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Sinocelltech Ltd. (5) · Institute of Hematology & Blood Diseases Hospital, China (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses omfiloctocog alfa is read from its arms, and is right about nine times in ten.
Testing it · 6
- ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer InhibitorRecruitingPhase 4Institute of Hematology & Blood Diseases Hospital, ChinaNCT05888870Written as SCT800 and Daratumumab
- Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.RecruitingPhase 4Sinocelltech Ltd.NCT03947567Written as Recombinant Human Coagulation FVIII
- Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia ACompletedPhase 3Sinocelltech Ltd.NCT03815318Written as Recombinant Human Coagulation FVIII
- Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.Status unknownPhase 3Sinocelltech Ltd.NCT03947320Written as Recombinant Human Coagulation FVIII
- Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia AStatus unknownPhase 3Sinocelltech Ltd.NCT02921945Written as SCT800
- Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia AStatus unknownPhase 1Sinocelltech Ltd.NCT02888223Written as SCT800
Codes
What other systems call omfiloctocog alfa · ClinicalTrials.gg INT015396
- UNII (FDA) 74D9ZOJ6IROMFILOCTOCOG ALFAOne source FDA
- NCI Thesaurus C175177Omfiloctocog AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 74D9ZOJ6IR | OMFILOCTOCOG ALFA | One source FDA |
| NCI Thesaurus | C175177 | Omfiloctocog Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.